November 08, 2013 / 11:42 IST
Moneycontrol Bureau
Enthused investors' aggressive buying took shares of
Aurobindo Pharma to 34-month high in intraday trade on Friday on better
September quarter results. The stock jumped 10 percent in morning trade on the BSE.
The drug company's consolidated net profit rose 5.7 percent to Rs 235 crore for the second quarter ended September 30, 2013 from Rs 222.4 crore year-on-year.
The company's total income from operations increased by 27.6 percent to Rs 1,913.9 crore Y-o-Y to Rs 1,500.4 crore.
"The integrated business in generic formulations is auguring well to drive the operating performance of the company. We are also investing in specific new, differentiated products offerings such as Oncology, Hormones, Peptides and OTC business which we believe will complement our business in the coming years," N Govindarajan, MD of the company said.
At 11:33 hrs, the stock was quoting at Rs 262.80, up Rs 24.45, or 10.26 percent on the BSE.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
